HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Satoh Selected Research

Muscle Weakness

2/2022Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report.
6/2006Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Satoh Research Topics

Disease

26Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2022 - 06/2005
22Myositis (Idiopathic Inflammatory Myopathies)
11/2023 - 02/2012
22Dermatomyositis (Dermatopolymyositis)
03/2022 - 06/2005
19Autoimmune Diseases (Autoimmune Disease)
01/2023 - 04/2004
18Systemic Scleroderma (Systemic Sclerosis)
10/2023 - 02/2007
18Inflammation (Inflammations)
11/2019 - 07/2004
16Rheumatic Diseases (Rheumatism)
12/2023 - 01/2006
15Rheumatoid Arthritis
06/2021 - 06/2005
13Neoplasms (Cancer)
10/2022 - 01/2006
12Interstitial Lung Diseases (Interstitial Lung Disease)
07/2023 - 06/2006
12Diabetic Nephropathies (Diabetic Nephropathy)
11/2019 - 02/2003
11Arthritis (Polyarthritis)
01/2021 - 07/2004
11Fibrosis (Cirrhosis)
01/2020 - 02/2001
9Polymyositis
03/2022 - 07/2011
8Infections
02/2021 - 01/2008
8Chronic Renal Insufficiency
11/2019 - 02/2008
7Muscular Diseases (Myopathy)
11/2023 - 04/2012
7Glomerulonephritis
11/2019 - 02/2007
7Proteinuria
11/2019 - 08/2002
6Nephritis
01/2021 - 08/2003
6Hypertension (High Blood Pressure)
01/2019 - 04/2008
5Hypertrophy
10/2016 - 09/2009
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2011 - 10/2007
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 06/2005
4Body Weight (Weight, Body)
01/2019 - 02/2003
4Hypoxia (Hypoxemia)
10/2018 - 01/2006
4Sclerosis
07/2011 - 02/2008
4Hypergammaglobulinemia (Hyperimmunoglobulinemia)
04/2011 - 02/2005
4Tertiary Lymphoid Structures
09/2009 - 04/2006
3Idiopathic Interstitial Pneumonias
10/2022 - 11/2017
3Calcinosis
01/2020 - 04/2012
3Albuminuria
01/2016 - 04/2008
3Vascular System Injuries
01/2011 - 10/2007
3Wounds and Injuries (Trauma)
12/2009 - 10/2007
3Lupus Nephritis
01/2009 - 08/2003
2Mixed Connective Tissue Disease (MCTD)
10/2023 - 07/2023
2Hypersensitivity (Allergy)
01/2023 - 01/2020
2Sjogren's Syndrome (Sjogren Syndrome)
06/2022 - 01/2009
2Connective Tissue Diseases (Connective Tissue Disease)
06/2022 - 01/2022
2Muscle Weakness
02/2022 - 06/2006
2Liver Diseases (Liver Disease)
01/2022 - 10/2011
2Undifferentiated Connective Tissue Diseases
01/2022 - 01/2020
2Necrosis
12/2020 - 04/2013
2Peritoneal Fibrosis
01/2020 - 08/2015
2Hemorrhage
08/2019 - 10/2011
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 11/2005
2Heart Failure
01/2019 - 06/2007

Drug/Important Bio-Agent (IBA)

71AutoantibodiesIBA
12/2023 - 08/2002
40AntibodiesIBA
11/2023 - 02/2006
20Biomarkers (Surrogate Marker)IBA
11/2023 - 09/2007
16Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2006
14pristane (pristan)IBA
01/2021 - 08/2002
10AntigensIBA
01/2022 - 05/2006
8Antinuclear AntibodiesIBA
01/2023 - 12/2004
8RNA (Ribonucleic Acid)IBA
02/2017 - 12/2005
7Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2023 - 01/2016
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 06/2003
7MicroRNAs (MicroRNA)IBA
04/2013 - 01/2006
7Interferon Type IIBA
06/2010 - 12/2005
6SMN Complex ProteinsIBA
10/2023 - 07/2011
6EnzymesIBA
02/2021 - 01/2006
6Immunoglobulin G (IgG)IBA
01/2018 - 02/2005
6Antigen-Antibody Complex (Immune Complex)IBA
04/2011 - 02/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2005
5Ligases (Synthetase)IBA
07/2019 - 06/2006
4CytokinesIBA
10/2018 - 02/2005
4InflammasomesIBA
01/2018 - 04/2013
4Ribavirin (Virazole)FDA LinkGeneric
12/2016 - 01/2011
4NADPH Oxidases (NAD(P)H oxidase)IBA
01/2016 - 06/2005
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
08/2015 - 12/2008
4HydrocarbonsIBA
02/2011 - 08/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009 - 07/2004
3Transfer RNA (tRNA)IBA
07/2019 - 06/2006
3Peptides (Polypeptides)IBA
03/2018 - 06/2008
3Immunoglobulin M (IgM)IBA
12/2016 - 01/2009
3InterferonsIBA
12/2016 - 05/2006
3Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2015 - 12/2008
3ChemokinesIBA
02/2014 - 01/2014
3LigandsIBA
01/2014 - 12/2005
3Superoxides (Superoxide)IBA
06/2013 - 06/2005
3RibonucleoproteinsIBA
05/2012 - 12/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011 - 01/2006
3Arginine (L-Arginine)FDA Link
12/2010 - 07/2006
3Angiotensin IIIBA
05/2010 - 02/2001
3Streptozocin (Streptozotocin)FDA Link
12/2008 - 02/2003
3Angiotensin II Type 1 Receptor BlockersIBA
12/2008 - 10/2007
2Signal Recognition ParticleIBA
11/2023 - 02/2021
2SteroidsIBA
03/2022 - 01/2021
2Pyruvic Acid (Pyruvate)IBA
01/2022 - 01/2018
2Oxidoreductases (Dehydrogenase)IBA
01/2022 - 01/2018
2Phosphotransferases (Kinase)IBA
02/2021 - 12/2020
2CreatinineIBA
02/2021 - 01/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 12/2004
2Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 01/2008
2InterleukinsIBA
01/2021 - 12/2020
2AcidsIBA
01/2019 - 04/2013
2Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 10/2007

Therapy/Procedure

12Therapeutics
03/2022 - 12/2004
3Nephrectomy
06/2012 - 09/2009
2Aftercare (After-Treatment)
03/2022 - 09/2003